Join Crystal Bio's Co-founder, CTO, and Head of USA BD Ye Gu, Ph.D., as she presents at the Immuno-Oncology Summit 2024.
Title: Analytical Methods to Assess Critical Quality Attribute in mRNA-LNP Modality
Phase-appropriate strategies are pivotal to ensure the analyses to be adequate at each stage. Employing advanced analytical techniques such as high-resolution mass spectrometry, properly and timely, can address potential CMC issues to mitigate risks of delaying progress. This presentation will discuss the application of phase-appropriate strategies for analyses needed at each stage, and related examples such as developability and serum stability studies will be illustrated to highlight the application.
Date: August 19-22, 2024
Location: Sheraton Boston (39 Dalton Street)
Booth: T13
